Mid-Term Results of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment
Purpose To evaluate the mid-term clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis (AC) resistant to medical treatments. Materials and Methods This is a prospective analysis performed between February 2016 and February 2020. Inclusion criteria for TAE were should...
Gespeichert in:
| Veröffentlicht in: | Cardiovascular and interventional radiology 2021-03, Vol.44 (3), p.443-451 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 451 |
|---|---|
| container_issue | 3 |
| container_start_page | 443 |
| container_title | Cardiovascular and interventional radiology |
| container_volume | 44 |
| creator | Fernández Martínez, Ana María Baldi, Sebastián Alonso-Burgos, Alberto López, Roberto Vallejo-Pascual, M. Eva Cuesta Marcos, M. Teresa Romero Alonso, David Rodríguez Prieto, Joaquín Mauriz, Jose Luis |
| description | Purpose
To evaluate the mid-term clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis (AC) resistant to medical treatments.
Materials and Methods
This is a prospective analysis performed between February 2016 and February 2020. Inclusion criteria for TAE were shoulder pain, restriction of movement and no response to conservative treatment for at least 3 months. Demographic variables, risk factors, technical aspects, adverse events, changes by visual analogue scale (VAS) for pain and physical examination before and after TAE were assessed.
Results
This study included 40 patients with AC (35 women and 5 men; mean age 50 ± 9 years old). Abnormal vessels were observed in 31/40 (77.5%) procedures. As embolic agent, imipenem/cilastatin was used. The mean follow-up was 21.2 ± 10.5 months. Significant differences were obtained in terms of pain reduction before and 6 months after TAE with the median visual analogue scale (VAS) of 8 vs. 0.5,
P
= 0.0001. Substantial differences were found regarding mobility in flexion and abduction before and 6 months after embolization, respectively (79.5° ± 18.5° vs. 133° ± 24.5°,
P
= 0.0001; 72.4° ± 18.8° vs. 129.7° ± 27.9°,
P
= 0.0001). No complications occurred. Complete recovery was obtained in 37/40 (92.5%) patients and partial recovery in 2/40 (5%). No clinical recurrence appeared.
Conclusions
Clinical results of transcatheter arterial embolization with imipenem/cilastatin are effective and stable in the mid-term follow-up for patients presenting with AC resistant to conservative treatments. |
| doi_str_mv | 10.1007/s00270-020-02682-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2456857184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2456857184</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-d04a2060ce38c8272d2205d1f9f52f15af63f00a97b0d1efd8b3e62ba3aefd5e3</originalsourceid><addsrcrecordid>eNp9kcFqFTEUhoMo9rb6Ai4k4MbN6EkyyaTLcmm1UBHkCu5CZubEpsxMrjmZgj69ud6q4MJFEsL5_j-Bj7EXAt4IgO4tAcgOGpCHZaxs2kdsI1olG7Dmy2O2AdG1jdBanLBTojsAoa3UT9mJUkJpIeyG0Yc4NjvMM_-EtE6FeAp8l_1Cgy-3WDDzi1z36Cd-Ofdpij98iWnhIdXJeIsU75Fv_b6GY4l0qIlU_FJ4SXybFsJ8XxMV2mX0ZcalPGNPgp8Inz-cZ-zz1eVu-765-fjuentx0wyq06UZofUSDAyo7GBlJ0cpQY8inActg9A-GBUA_HnXwygwjLZXaGTvla8XjeqMvT727nP6tiIVN0cacJr8gmklJ1ttrO6EbSv66h_0Lq15qb-rlDVGKtCmUvJIDTkRZQxun-Ps83cnwB2UuKMSV5W4X0rcofrlQ_Xazzj-ifx2UAF1BKiOlq-Y_779n9qf2NmYZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2486623056</pqid></control><display><type>article</type><title>Mid-Term Results of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment</title><source>SpringerNature Journals</source><creator>Fernández Martínez, Ana María ; Baldi, Sebastián ; Alonso-Burgos, Alberto ; López, Roberto ; Vallejo-Pascual, M. Eva ; Cuesta Marcos, M. Teresa ; Romero Alonso, David ; Rodríguez Prieto, Joaquín ; Mauriz, Jose Luis</creator><creatorcontrib>Fernández Martínez, Ana María ; Baldi, Sebastián ; Alonso-Burgos, Alberto ; López, Roberto ; Vallejo-Pascual, M. Eva ; Cuesta Marcos, M. Teresa ; Romero Alonso, David ; Rodríguez Prieto, Joaquín ; Mauriz, Jose Luis</creatorcontrib><description>Purpose
To evaluate the mid-term clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis (AC) resistant to medical treatments.
Materials and Methods
This is a prospective analysis performed between February 2016 and February 2020. Inclusion criteria for TAE were shoulder pain, restriction of movement and no response to conservative treatment for at least 3 months. Demographic variables, risk factors, technical aspects, adverse events, changes by visual analogue scale (VAS) for pain and physical examination before and after TAE were assessed.
Results
This study included 40 patients with AC (35 women and 5 men; mean age 50 ± 9 years old). Abnormal vessels were observed in 31/40 (77.5%) procedures. As embolic agent, imipenem/cilastatin was used. The mean follow-up was 21.2 ± 10.5 months. Significant differences were obtained in terms of pain reduction before and 6 months after TAE with the median visual analogue scale (VAS) of 8 vs. 0.5,
P
= 0.0001. Substantial differences were found regarding mobility in flexion and abduction before and 6 months after embolization, respectively (79.5° ± 18.5° vs. 133° ± 24.5°,
P
= 0.0001; 72.4° ± 18.8° vs. 129.7° ± 27.9°,
P
= 0.0001). No complications occurred. Complete recovery was obtained in 37/40 (92.5%) patients and partial recovery in 2/40 (5%). No clinical recurrence appeared.
Conclusions
Clinical results of transcatheter arterial embolization with imipenem/cilastatin are effective and stable in the mid-term follow-up for patients presenting with AC resistant to conservative treatments.</description><identifier>ISSN: 0174-1551</identifier><identifier>EISSN: 1432-086X</identifier><identifier>DOI: 10.1007/s00270-020-02682-4</identifier><identifier>PMID: 33135118</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adhesion tests ; Adverse events ; Antibiotics ; Cardiology ; Clinical Investigation ; Complications ; Demographic variables ; Embolisation (arterial) ; Embolization ; Health services ; Imaging ; Imipenem ; Joint diseases ; Medical materials ; Medical treatment ; Medicine ; Medicine & Public Health ; Nuclear Medicine ; Pain ; Patients ; Radiology ; Risk analysis ; Risk factors ; Shoulder ; Ultrasound</subject><ispartof>Cardiovascular and interventional radiology, 2021-03, Vol.44 (3), p.443-451</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-d04a2060ce38c8272d2205d1f9f52f15af63f00a97b0d1efd8b3e62ba3aefd5e3</citedby><cites>FETCH-LOGICAL-c375t-d04a2060ce38c8272d2205d1f9f52f15af63f00a97b0d1efd8b3e62ba3aefd5e3</cites><orcidid>0000-0003-4835-7976</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00270-020-02682-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00270-020-02682-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33135118$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fernández Martínez, Ana María</creatorcontrib><creatorcontrib>Baldi, Sebastián</creatorcontrib><creatorcontrib>Alonso-Burgos, Alberto</creatorcontrib><creatorcontrib>López, Roberto</creatorcontrib><creatorcontrib>Vallejo-Pascual, M. Eva</creatorcontrib><creatorcontrib>Cuesta Marcos, M. Teresa</creatorcontrib><creatorcontrib>Romero Alonso, David</creatorcontrib><creatorcontrib>Rodríguez Prieto, Joaquín</creatorcontrib><creatorcontrib>Mauriz, Jose Luis</creatorcontrib><title>Mid-Term Results of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment</title><title>Cardiovascular and interventional radiology</title><addtitle>Cardiovasc Intervent Radiol</addtitle><addtitle>Cardiovasc Intervent Radiol</addtitle><description>Purpose
To evaluate the mid-term clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis (AC) resistant to medical treatments.
Materials and Methods
This is a prospective analysis performed between February 2016 and February 2020. Inclusion criteria for TAE were shoulder pain, restriction of movement and no response to conservative treatment for at least 3 months. Demographic variables, risk factors, technical aspects, adverse events, changes by visual analogue scale (VAS) for pain and physical examination before and after TAE were assessed.
Results
This study included 40 patients with AC (35 women and 5 men; mean age 50 ± 9 years old). Abnormal vessels were observed in 31/40 (77.5%) procedures. As embolic agent, imipenem/cilastatin was used. The mean follow-up was 21.2 ± 10.5 months. Significant differences were obtained in terms of pain reduction before and 6 months after TAE with the median visual analogue scale (VAS) of 8 vs. 0.5,
P
= 0.0001. Substantial differences were found regarding mobility in flexion and abduction before and 6 months after embolization, respectively (79.5° ± 18.5° vs. 133° ± 24.5°,
P
= 0.0001; 72.4° ± 18.8° vs. 129.7° ± 27.9°,
P
= 0.0001). No complications occurred. Complete recovery was obtained in 37/40 (92.5%) patients and partial recovery in 2/40 (5%). No clinical recurrence appeared.
Conclusions
Clinical results of transcatheter arterial embolization with imipenem/cilastatin are effective and stable in the mid-term follow-up for patients presenting with AC resistant to conservative treatments.</description><subject>Adhesion tests</subject><subject>Adverse events</subject><subject>Antibiotics</subject><subject>Cardiology</subject><subject>Clinical Investigation</subject><subject>Complications</subject><subject>Demographic variables</subject><subject>Embolisation (arterial)</subject><subject>Embolization</subject><subject>Health services</subject><subject>Imaging</subject><subject>Imipenem</subject><subject>Joint diseases</subject><subject>Medical materials</subject><subject>Medical treatment</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nuclear Medicine</subject><subject>Pain</subject><subject>Patients</subject><subject>Radiology</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Shoulder</subject><subject>Ultrasound</subject><issn>0174-1551</issn><issn>1432-086X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kcFqFTEUhoMo9rb6Ai4k4MbN6EkyyaTLcmm1UBHkCu5CZubEpsxMrjmZgj69ud6q4MJFEsL5_j-Bj7EXAt4IgO4tAcgOGpCHZaxs2kdsI1olG7Dmy2O2AdG1jdBanLBTojsAoa3UT9mJUkJpIeyG0Yc4NjvMM_-EtE6FeAp8l_1Cgy-3WDDzi1z36Cd-Ofdpij98iWnhIdXJeIsU75Fv_b6GY4l0qIlU_FJ4SXybFsJ8XxMV2mX0ZcalPGNPgp8Inz-cZ-zz1eVu-765-fjuentx0wyq06UZofUSDAyo7GBlJ0cpQY8inActg9A-GBUA_HnXwygwjLZXaGTvla8XjeqMvT727nP6tiIVN0cacJr8gmklJ1ttrO6EbSv66h_0Lq15qb-rlDVGKtCmUvJIDTkRZQxun-Ps83cnwB2UuKMSV5W4X0rcofrlQ_Xazzj-ifx2UAF1BKiOlq-Y_779n9qf2NmYZQ</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Fernández Martínez, Ana María</creator><creator>Baldi, Sebastián</creator><creator>Alonso-Burgos, Alberto</creator><creator>López, Roberto</creator><creator>Vallejo-Pascual, M. Eva</creator><creator>Cuesta Marcos, M. Teresa</creator><creator>Romero Alonso, David</creator><creator>Rodríguez Prieto, Joaquín</creator><creator>Mauriz, Jose Luis</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4835-7976</orcidid></search><sort><creationdate>20210301</creationdate><title>Mid-Term Results of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment</title><author>Fernández Martínez, Ana María ; Baldi, Sebastián ; Alonso-Burgos, Alberto ; López, Roberto ; Vallejo-Pascual, M. Eva ; Cuesta Marcos, M. Teresa ; Romero Alonso, David ; Rodríguez Prieto, Joaquín ; Mauriz, Jose Luis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-d04a2060ce38c8272d2205d1f9f52f15af63f00a97b0d1efd8b3e62ba3aefd5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adhesion tests</topic><topic>Adverse events</topic><topic>Antibiotics</topic><topic>Cardiology</topic><topic>Clinical Investigation</topic><topic>Complications</topic><topic>Demographic variables</topic><topic>Embolisation (arterial)</topic><topic>Embolization</topic><topic>Health services</topic><topic>Imaging</topic><topic>Imipenem</topic><topic>Joint diseases</topic><topic>Medical materials</topic><topic>Medical treatment</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nuclear Medicine</topic><topic>Pain</topic><topic>Patients</topic><topic>Radiology</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Shoulder</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fernández Martínez, Ana María</creatorcontrib><creatorcontrib>Baldi, Sebastián</creatorcontrib><creatorcontrib>Alonso-Burgos, Alberto</creatorcontrib><creatorcontrib>López, Roberto</creatorcontrib><creatorcontrib>Vallejo-Pascual, M. Eva</creatorcontrib><creatorcontrib>Cuesta Marcos, M. Teresa</creatorcontrib><creatorcontrib>Romero Alonso, David</creatorcontrib><creatorcontrib>Rodríguez Prieto, Joaquín</creatorcontrib><creatorcontrib>Mauriz, Jose Luis</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular and interventional radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fernández Martínez, Ana María</au><au>Baldi, Sebastián</au><au>Alonso-Burgos, Alberto</au><au>López, Roberto</au><au>Vallejo-Pascual, M. Eva</au><au>Cuesta Marcos, M. Teresa</au><au>Romero Alonso, David</au><au>Rodríguez Prieto, Joaquín</au><au>Mauriz, Jose Luis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mid-Term Results of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment</atitle><jtitle>Cardiovascular and interventional radiology</jtitle><stitle>Cardiovasc Intervent Radiol</stitle><addtitle>Cardiovasc Intervent Radiol</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>44</volume><issue>3</issue><spage>443</spage><epage>451</epage><pages>443-451</pages><issn>0174-1551</issn><eissn>1432-086X</eissn><abstract>Purpose
To evaluate the mid-term clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis (AC) resistant to medical treatments.
Materials and Methods
This is a prospective analysis performed between February 2016 and February 2020. Inclusion criteria for TAE were shoulder pain, restriction of movement and no response to conservative treatment for at least 3 months. Demographic variables, risk factors, technical aspects, adverse events, changes by visual analogue scale (VAS) for pain and physical examination before and after TAE were assessed.
Results
This study included 40 patients with AC (35 women and 5 men; mean age 50 ± 9 years old). Abnormal vessels were observed in 31/40 (77.5%) procedures. As embolic agent, imipenem/cilastatin was used. The mean follow-up was 21.2 ± 10.5 months. Significant differences were obtained in terms of pain reduction before and 6 months after TAE with the median visual analogue scale (VAS) of 8 vs. 0.5,
P
= 0.0001. Substantial differences were found regarding mobility in flexion and abduction before and 6 months after embolization, respectively (79.5° ± 18.5° vs. 133° ± 24.5°,
P
= 0.0001; 72.4° ± 18.8° vs. 129.7° ± 27.9°,
P
= 0.0001). No complications occurred. Complete recovery was obtained in 37/40 (92.5%) patients and partial recovery in 2/40 (5%). No clinical recurrence appeared.
Conclusions
Clinical results of transcatheter arterial embolization with imipenem/cilastatin are effective and stable in the mid-term follow-up for patients presenting with AC resistant to conservative treatments.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33135118</pmid><doi>10.1007/s00270-020-02682-4</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-4835-7976</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0174-1551 |
| ispartof | Cardiovascular and interventional radiology, 2021-03, Vol.44 (3), p.443-451 |
| issn | 0174-1551 1432-086X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2456857184 |
| source | SpringerNature Journals |
| subjects | Adhesion tests Adverse events Antibiotics Cardiology Clinical Investigation Complications Demographic variables Embolisation (arterial) Embolization Health services Imaging Imipenem Joint diseases Medical materials Medical treatment Medicine Medicine & Public Health Nuclear Medicine Pain Patients Radiology Risk analysis Risk factors Shoulder Ultrasound |
| title | Mid-Term Results of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T05%3A18%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mid-Term%20Results%20of%20Transcatheter%20Arterial%20Embolization%20for%20Adhesive%20Capsulitis%20Resistant%20to%20Conservative%20Treatment&rft.jtitle=Cardiovascular%20and%20interventional%20radiology&rft.au=Fern%C3%A1ndez%20Mart%C3%ADnez,%20Ana%20Mar%C3%ADa&rft.date=2021-03-01&rft.volume=44&rft.issue=3&rft.spage=443&rft.epage=451&rft.pages=443-451&rft.issn=0174-1551&rft.eissn=1432-086X&rft_id=info:doi/10.1007/s00270-020-02682-4&rft_dat=%3Cproquest_cross%3E2456857184%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2486623056&rft_id=info:pmid/33135118&rfr_iscdi=true |